- Home
- ALDX vs BKSY Comparison
ALDX vs BKSY Comparison
Compare ALDX & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- BKSY
- Stock Information
- Founded
- ALDX 2004
- BKSY 2013
- Country
- ALDX United States
- BKSY United States
- Employees
- ALDX N/A
- BKSY N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- BKSY Radio And Television Broadcasting And Communications Equipment
- Sector
- ALDX Health Care
- BKSY Technology
- Exchange
- ALDX Nasdaq
- BKSY Nasdaq
- Market Cap
- ALDX 304.9M
- BKSY 303.5M
- IPO Year
- ALDX 2014
- BKSY N/A
- Fundamental
- Price
- ALDX $6.71
- BKSY $8.74
- Analyst Decision
- ALDX Strong Buy
- BKSY Strong Buy
- Analyst Count
- ALDX 2
- BKSY 5
- Target Price
- ALDX $10.00
- BKSY $21.80
- AVG Volume (30 Days)
- ALDX 666.8K
- BKSY 1.7M
- Earning Date
- ALDX 05-01-2025
- BKSY 03-06-2025
- Dividend Yield
- ALDX N/A
- BKSY N/A
- EPS Growth
- ALDX N/A
- BKSY N/A
- EPS
- ALDX N/A
- BKSY N/A
- Revenue
- ALDX N/A
- BKSY $102,093,000.00
- Revenue This Year
- ALDX N/A
- BKSY $33.53
- Revenue Next Year
- ALDX N/A
- BKSY $33.06
- P/E Ratio
- ALDX N/A
- BKSY N/A
- Revenue Growth
- ALDX N/A
- BKSY 8.04
- 52 Week Low
- ALDX $2.75
- BKSY $3.86
- 52 Week High
- ALDX $7.20
- BKSY $21.92
- Technical
- Relative Strength Index (RSI)
- ALDX 57.30
- BKSY 33.83
- Support Level
- ALDX $6.22
- BKSY $8.52
- Resistance Level
- ALDX $7.20
- BKSY $9.49
- Average True Range (ATR)
- ALDX 0.53
- BKSY 0.94
- MACD
- ALDX -0.01
- BKSY -0.26
- Stochastic Oscillator
- ALDX 79.59
- BKSY 6.51
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.